THE CHALLENGES OF MANAGING CROSS-FUNCTIONAL TEAMS IN PHARMACEUTICAL PROJECTS

Feruzakhon Murodova

THE CHALLENGES OF MANAGING CROSS-FUNCTIONAL TEAMS IN PHARMACEUTICAL PROJECTS

##article.authors##

Feruzakhon Murodova

##semicolon##

cross-functional teams, pharmaceutical projects, communication, project management, coordination, regulatory environment, communication, conflicting priorities, documentation, data management

##article.abstract##

The increasing complexity of pharmaceutical projects has significantly strengthened the role of cross-functional
teams in ensuring successful project implementation. Such teams integrate specialists from different departments,
including quality assurance, production, regulatory affairs, and supply chain. While this structure allows organizations to
combine diverse expertise, it also creates several managerial challenges.
This study aims to identify and analyze the key difficulties associated with managing cross-functional teams within
a pharmaceutical company. The empirical research is based on data collected from employees of FE LLC “Nobel
Pharmsanoat” using a structured questionnaire. The results show that communication gaps, conflicting priorities between
departments, and issues related to documentation and data management have the strongest impact on project outcomes.
At the same time, regulatory pressure, although significant, has a less direct influence on team effectiveness. The findings
highlight the importance of improving coordination mechanisms, clarifying roles and responsibilities, and strengthening
communication processes to enhance project performance.

##submission.authorBiography##

Feruzakhon Murodova

Student of the Graduate School of Business and Entrepreneurship
under the Cabinet of Ministers of the Republic of Uzbekistan

##submission.citations##

1. Ancona, D. G., & Caldwell, D. F. (1992). Demography and design: Predictors of new product team performance.

Organization Science, 3(3), 321–341. https://doi.org/10.1287/orsc.3.3.321

2. Project Management Institute. (2021). A Guide to the Project Management Body of Knowledge (PMBOK® Guide). 7th

ed.

3. Salas, E., Sims, D. E., & Burke, C. S. (2005). Is there a “Big Five” in teamwork? Small Group Research, 36(5), 555–

599. https://doi.org/10.1177/1046496405277134

4. Anantatmula, V. S., & Shrivastav, B. (2016). Evolution of project teams for Generation Y workforce. Business Process

Management Journal, 22(1), 9–26.

5. International Council for Harmonisation. (2008). ICH Q10: Pharmaceutical Quality System.

6. International Council for Harmonisation. (2008). ICH Q10: Pharmaceutical Quality System.

7. Ménard, T., Young, K., Siegel, L., Emerson, J., Studt, R., & Sidor, L. (2021). Cross-company collaboration to leverage

analytics for clinical quality and accelerate drug development: The IMPALA industry group.

8. VanDuyse, S. A. (2021). ICH Q10 Pharmaceutical Quality System Guidance.

9. Murodova, F. (2025). Applying the Agile Approach to Project Management: A Case Study of a Traditional Finished

Pharmaceutical Products Manufacturer. Advanced Economics and Pedagogical Technologies, 2(4), 132–136. https://

doi.org/10.60078/3060-4842-2025-vol2-iss4-pp132-136

10. Suyunov, D. Kh., & Makhsudov, M. I. (2023). Benefits of Digitalization of the Economy in Uzbekistan. Economy and

Society, 748–751.

11. Nasimov, B. V. (2025). Development Strategies for Global Companies in Current Conditions. Marketing Journal, No. 3.

THE CHALLENGES OF MANAGING CROSS-FUNCTIONAL TEAMS IN PHARMACEUTICAL PROJECTS